{"id":"W4223492952","doi":"10.1016/j.celrep.2022.110634","title":"Melanomas with concurrent BRAF non-p.V600 and NF1 loss-of-function mutations are targetable by BRAF/MEK inhibitor combination therapy","year":2022,"lang":"en","type":"article","venue":"Cell Reports","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"ca_institutions":"Jewish General Hospital; McGill University Health Centre; Sunnybrook Health Science Centre; Health Sciences Centre; University of British Columbia; McGill University","funders":"Canadian Institutes of Health Research","keywords":"Neuroblastoma RAS viral oncogene homolog; Melanoma; Mutant; Cancer research; MEK inhibitor; Mutation; Combination therapy; Trametinib; Context (archaeology); In vivo; Targeted therapy; Medicine; MAPK/ERK pathway; Biology; Kinase; Cancer; KRAS; Pharmacology; Genetics; Internal medicine; Gene","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001201412,0.0002294128,0.0002978977,0.0001953017,0.0001815829,0.0002806973,0.0001022422,0.0001669133,0.001213199],"category_scores_gemma":[0.0001786283,0.0001161588,0.0002129484,0.0001151528,0.000139009,0.0001486223,0.0001323044,0.0003958608,0.0002833364],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001942987,"about_ca_system_score_gemma":0.0001504362,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004198558,"about_ca_topic_score_gemma":0.001247627,"domain_scores_codex":[0.9999099,0.00001521452,0.000006394977,0.00001762631,0.00002837679,0.00002242341],"domain_scores_gemma":[0.9999266,0.0000119521,0.00002160862,0.000009025774,0.000004934377,0.00002598607],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00125438,0.0004268836,0.01954629,0.00008671414,0.00006644218,0.006282076,0.00004123648,0.0002680499,0.9386002,0.0003308715,0.0005734347,0.03252339],"study_design_scores_gemma":[0.0004409106,0.008051787,0.3372891,0.00003818775,0.000284259,0.1256737,0.0002008261,0.004721436,0.5025837,0.0008019168,0.01988022,0.00003390043],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.990961,0.002499818,0.0009753908,0.0001033962,0.00002594557,0.00004726705,0.00006718856,0.00007203895,0.005247878],"genre_scores_gemma":[0.9981161,0.0004533671,0.0004049941,0.00003608798,0.00001112112,0.00001068229,0.00008421812,0.000004877912,0.0008786424],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001213199,"threshold_uncertainty_score":0.00405854,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006085928717589404,"score_gpt":0.2001417703925887,"score_spread":0.1940558416749993,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}